No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics

Biological Psychiatry

Volumn 43, Issue 3, 1998, Pages 205-209

  Murphy Jr , Greer M ^a   Lim, Kelvin O ^a,c   Wieneke, Mary ^e   Ellis, William G ^b   Forno, Lysia S ^d   Hoff, Anne L ^e   Nordahl, Thomas ^b,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Psychiatry Service   (United States)

^d Napa State Hospital ^*  (United States)

^e Napa State Hospital   (United States)

Author keywords

Alzheimer's disease; Antipsychotic agents; Dementia; Neuropathology; Schizophrenia

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; HUMAN; MAJOR CLINICAL STUDY; NERVE DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SOLDIER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 0032005053     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00031-0     Document Type: Article

References (23)

1. Arnold SE, Franz BR, Trojanowski JQ (1994): Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging 15:299-303.
2. Arnold SE, Gur RE, Shapiro RM, et al (1995): Prospective clinicopathologic studies of schizophrenia: Accrual and assessment of patients. Am J Psychiatry 152:731-737.
3. Arnold SE, Trojanowski JQ (1996): Cognitive impairment in elderly schizophrenia: A dementia (still) lacking distinctive histopathology. Schizophr Bull 22:5-9.
4. Baldessarini RJ, Hegarty JD, Bird ED, Benes FM (1997): Postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia: A meta-analysis. Am J Psychiatry. 154:861-863.
5. Buhl L, Bojsen-Moller M (1988): Frequency of Alzheimer's disease in a postmortem study of psychiatric patients. Dan Med Bull 35:288-290.
6. Casanova MF, Carosella NW, Gold JM, Kleinman JE, Weinberger DR, Powers RE (1993): A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Psychiatry Res 49:41-62.
7. Cordell B (1994): β-amyloid formation as a potential therapeutic target for Alzheimer's disease. Annu Rev Pharmacol Toxicol 34:69-89.
8. Corsellis JAN (1962): Mental illness and the ageing brain. The distribution of pathological change in a mental hospital population. Institute of Psychiatry, Maudsley Monograph No. 9. London: Oxford University Press, pp 1-76.
9. Goldberg TE, Hyde TM, Kleinman JE, Weinberger DR (1993): Course of schizophrenia: Neuropsychological evidence for a static encephalopathy. Schizophr Bull 4:797-804.
10. Harvey PD, White L, Parrella M, et al (1995): The longitudinal stability of cognitive impairment in schizophrenia. Br J Psychiatry 166:630-633.
11. Heaton R, Paulsen JS, McAdams LA, et al (1994): Neuropsychological deficits in schizophrenia. Relationship to age, chronicity, and dementia. Arch Gen Psychiatry 51:469-476.
12. Higaki J, Murphy GM, Cordell B (1997): Inhibition of β-amyloid formation by haloperidol: A possible mechanism in reduced frequency of Alzheimer's disease pathology in schizophrenia. J Neurochem 68:333-336.
13. Khachaturian ZS (1985): Diagnosis of Alzheimer's disease. Arch Neurol 452:1097-1105.
14. Nizato K, Ikeda K (1996): Long-term antipsychotic medication of schizophrenics does not promote the development of Alzheimer's disease brain pathology. J Neurol Sci 138:165-167.
15. Oken RJ, McGeer PL (1995): Schizophrenia: A 100 year perspective. Am J Psychiatry 152:1692-1693.
16. Powchik P, Davidson M, Nemeroff CB, et al (1993): Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment. Am J Psychiatry 150:1726-1727.
17. Prohovnik I, Dwork A, Kaufman MA, Willson N (1993): Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull 4:805-816.
18. Purohit DP, Davidson M, Perl DP, et al (1993): Severe cognitive impairment in elderly schizophrenic patients: A clinicopathological study. Biol Psychiatry 33:255-260.
19. Rockwood K, Stadnyk K (1994): The prevalence of dementia in the elderly: A review. Can J Psychiatry 39:253-257.
20. Soustek Z (1989): Ultrastructure of cortical synapses in the brain of schizophrenics. Zentralbl Allg Pathol 135:25-32.
21. Wisniewski HM, Constantinidis J, Wegiel J, Bobinksi M, Tarnawski M (1994): Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Dis Assoc Disord 8:211-227.
22. Yamamoto T, Hirano A (1986): A comparative study of the modified Bielschowsky, Bodian, and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol 12:3-9.
23. Zhu S, Nothen MM, Uhlhaas S, et al (1996): Apolipoprotein E genotype distribution in schizophrenia. Psychiatr Genet 6:75-79.